Designer gene therapy using an Escherichia coli purine nucleoside phosphorylase/prodrug system.
Bennett, E.M., Anand, R., Allan, P.W., Hassan, A.E., Hong, J.S., Levasseur, D.N., McPherson, D.T., Parker, W.B., Secrist, J.A., Sorscher, E.J., Townes, T.M., Waud, W.R., Ealick, S.E.(2003) Chem.Biol. 10: 1173-1181
- PubMed: 14700625 
- Primary Citation of Related Structures:  
- PubMed Abstract: 
Activation of prodrugs by Escherichia coli purine nucleoside phosphorylase (PNP) provides a method for selectively killing tumor cells expressing a transfected PNP gene. This gene therapy approach requires matching a prodrug and a known enzymatic act ...